Gene Query: MRPL32

Dataset Description Geneva Score
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 255.11
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 22.98
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 22.98
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 20.95
Comparison of microRNA Profiling Platforms 19.94
Comparison of microRNA Profiling Platforms (HTS) 19.94
MeRIP-seq for heat shock in B-cell lymphoma cells 19.83
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 19.06
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 18.72
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 18.69
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 18.38
CD95/Fas ligand mRNA is toxic to cells 17.24
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 16.37
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 15.5
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 14.99
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 14.97
Systematic discovery of endogenous human ribonucleoprotein complexes 13.92
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 11.83
Comprehensive comparative analysis of 5’ end RNA sequencing methods 11.71
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.47
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 11.08
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.03
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 10.78
Cajal bodies are linked to genome conformation 10.46
Cajal bodies are linked to genome conformation [RNA-Seq] 10.46
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 10.45
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.33
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 10.32
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 10.24
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 10.1
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 10.1
Seletive inhibition of CDK9 in DLBCL cell lines 9.95
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 9.61
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 9.61
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 9.61
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 9.48
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 9.25
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 9.25
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.2
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 9.09
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 8.85
Global analysis of enhancer targets: Mosaic-seq 8.81
RNA-Seq from early time points in the kidney differentiation protocol 8.77
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 8.76
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 8.76
DART-seq: an antibody-free method for global m6A detection 8.73
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 8.62
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.51
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 8.32
The evolution of N6-methyladenosine in primates 8.26
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 8.17
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.08
scRNASeq analysis of cycling cardiomyocytes 8.05
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.01
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.01
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 7.96
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.96
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.92
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.92
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 7.91
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.89
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.89
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 7.81
IDH3a KO RNA-seq 7.78
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.72
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.68
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.65
The cohesin complex prevents Myc-induced replication stress 7.58
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.51
Integrin signaling regulates YAP/TAZ to control skin homeostasis 7.48
Gene expression changes after LOC550643 silencing 7.43
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.41
RNA-Seq with and without RNase treatment in PCa cell lines 7.39
Regulation of protein translation during mitosis 7.39
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 7.27
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.27
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 7.22
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 7.1
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 7.06
miRNAs affected by antagomiR-17 treatment 7.04
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 6.91
Developmental stage specific chromosome architecture in human erythroid cells 6.9
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 6.9
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 6.87
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 6.82
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 6.8
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.71
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.66
Trans-differentiation of human adult peripheral blood T cells into neurons 6.66
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 6.63
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.62
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.62
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.62
Identification of HOXB13 target genes responsive to BET inhibitors 6.6
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 6.58
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 6.55
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 6.52
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.51
Total RNA-seq in ALL-SIL upon TLX1 knockdown 6.5
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.43
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 6.43
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 6.42
Differetially expressed genes after hTR overexpression in U2OS cells 6.41
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.4
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.38
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.34
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.34
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.33
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.26
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 6.26
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.21
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.17
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 6.14
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 6.13
Single-cell analysis of human kidney organoids 6.09
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.09
Uridylation by TUT4 and TUT7 marks mRNA for degradation 6.08
Expression by CD133+ cells isolated from the adult human exocrine pancreas 6.07
Transcriptome of activated human and mouse MAIT cells 6.06
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.05
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 6.01
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.99
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 5.94
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 5.86
The landscape of alternative splicing in aggressive prostate cancers 5.86
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.86
MYC dependent mRNA translation shapes gene expression and cell biology 5.8
Gene expression analysis upon mtDNA depletion 5.8
Gene expression analysis upon mtDNA depletion [RNA-seq] 5.8
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.73
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.72
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.69
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 5.66
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.66
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.64
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 5.59
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.57
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.56
Rorc disruption in human FG pancreatic cancer cells 5.56
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.53
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.53
ETV7 and interferon response 5.49
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.49
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.47
Human embryonic stem cells in E8 and AKIT culture medium 5.4
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 5.4
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 5.38
Role for citron kinase in prostate cancer growth 5.37
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.35
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 5.32
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 5.23
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 5.21
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 5.17
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.15
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.13
RNA-seq of naive and primed ES cells (NHSM) 5.11
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.09
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.07
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 5.07
Lysine benzoylation is a novel histone mark [RNA-seq] 5.06
Lysine benzoylation is a novel histone mark 5.06
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 5.04
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.01
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 4.99
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 4.99
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 4.98
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 4.98
The comparison of high-throughput single-cell RNA-seq methods 4.97
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 4.96
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 4.95
Differential Gene Expression between MCF10A and MCF7 cells 4.93
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.93
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.92
FBXW7 modulates stress response by post-translational modification of HSF1 4.92
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.92
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.91
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.88
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 4.88
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 4.85
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 4.85
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 4.85
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.82
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.81
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.76
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.75
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 4.72
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 4.72
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.69
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.68
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.68
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.67
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.66
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 4.64
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 4.63
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 4.61
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.57
Selective expression of long non-coding RNAs in a breast cancer cell progression model 4.57
Lineage specific differentiation is influenced by state of human pluripotency 4.52
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 4.52
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 4.52
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.51
Noncoding regions are the main source of targetable tumor-specific antigens 4.49
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 4.48
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 4.47
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 4.46
Functional role of SLIT2 and ROBO1 in trophoblasts 4.41
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 4.32
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.31
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 4.31
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.31
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.29
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.28
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.27
RNAseq Study in CC-671 Treated Cal-51 Cells 4.25
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.2
mRNA expression profile of Lymphocytes 4.2
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 4.19
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 4.19
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 4.19
RNA-sequencing of healthy human skeletal myocytes 4.17
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.16
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.16
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 4.14
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.14
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.13
RNA-seq analyisis of PUM2 knockout cells 4.13
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.12
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.12
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.07
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.07
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.05
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.03
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 4.0
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.98
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 3.94
Effect of CHKA knockdown on C4-2 cell transcriptome 3.94
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.93
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.92
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.92
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.9
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.89
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 3.88
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.81
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.81
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 3.81
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.78
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.77
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.76
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.76
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.71
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.7
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.7
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.7
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.68
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 3.67
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 3.65
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 3.6
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 3.58
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.57
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 3.56
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 3.55
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 3.55
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.55
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.55
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.53
Cell responses to dysregulated VZV-induced cell-cell fusion 3.5
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 3.49
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 3.49
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.45
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 3.43
Gene expression in GBM with Cav3.2 inhibition 3.41
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.4
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.39
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.35
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.34
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 3.34
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.28
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 3.23
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 3.21
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.17
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.16
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.14
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.14
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.13
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.13
Hepatitis C virus functionally sequesters miR-122 3.12
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.12
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.12
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.09
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.06
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.06
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.01
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.95
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.91
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 2.9
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 2.9
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 2.89
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.83
Effect of ILF3 on translation during homeostasis and the antiviral response 2.79
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.78
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.76
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.76
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.76
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.75
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.7
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.68
Epigenomic conservation of transposable element silencing 2.65
Epigenomic conservation of transposable element silencing [RNA-seq] 2.65
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.65
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.65
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.63
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.63
Overexpression and knockdown experiment for circCSNK1G3 2.58
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.56
Chromatin landscape of human visceral and subcutaneous adipocytes 2.52
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.51
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.51
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.49
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.49
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.48
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.48
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.47
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 2.46
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.45
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.35
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.35
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.35
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.34
Real-time observation of light-controlled transcription in living cells 2.34
An integrative analysis of non-coding regulatory DNA variations associated with autism 2.32
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.32
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.32
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.32
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.32
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 2.31
Effect of PBK knockdown on C4-2 cell transcriptome 2.3
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.28
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.27
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.25
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.21
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.21
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 2.2
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 2.2
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.2
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 2.17
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.12
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.11
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.08
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.07
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.05
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.05
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.04
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.04
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.03
Impact on erythroid progenitor type on erythroid differntiation 2.0
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.99
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.98
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.91
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.9
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.88
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.88
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.87
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.87
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.87
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.87
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.87
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.86
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.83
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.83
Human cells contain natural double-stranded RNAs with potential regulatory capacity 1.82
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.82
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 1.81
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.79
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.77
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.77
RNA sequencing of mechanically strained NHEKs and control NHEKs 1.77
Illumina Total RNA-seq in HeLa 1.76
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.76
CD73 knockdown effect in pancreatic cancer cell lines 1.74
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.7
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.68
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.65
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.65
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.64
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.63
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.59
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.59
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.53
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.51
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.48
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.45
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.45
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.39
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.38
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.38
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.34
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.33
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.32
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.31
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.31
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.3
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.3
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.29
Functional significance of the HIV-1 Tat signature amino acid residues 1.29
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.29
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.29
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.27
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 1.23
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.2
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.19
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 1.19
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.18
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.17
RNA-seq data 1.16
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.12
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.11
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 1.1
RNA seq with AML (NB4) cells upon FTO inhibition 1.09
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.09
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.08
SLAM-seq for K562 endogenous mRNA decay 1.05
Downregulation of LATS kinases alters p53 to promote cell migration 1.05
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.03
SF3B1 Degron knockdown RNA-seq 1.02
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.0
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.91
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.89
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.89
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.87
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.85
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.84
Genome-wide analysis of the Integrator complex (HTS) 0.83
Genome-wide analysis of the Integrator complex 0.83
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.76
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.76
p53 activity results in DNA replication fork processivity 0.76
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.74
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.73
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.71
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.69
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.69
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.67
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.67
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.66
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.64
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.64
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.63
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.63
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.62
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.62
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.61
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.58
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.58
Induced DNA demethylation, genome instability and transcription 0.58
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.58
Global transcriptome analysis of WT versus HEB-/- hESCs 0.57
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.56
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.55
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.5
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.49
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.48
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.47
HBEC-shp53-PCHD7 0.45
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.44
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.44
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.43
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.42
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.42
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.4
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.4
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.38
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.38
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.37
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.37
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.33
Loss of CREBBP results in gene expression repression in lymphoma cells 0.33
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.32
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.32
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.32
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.31
RNA-seq of IL-4 stimulated human keratinocytes 0.28
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.23
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.22
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.2
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.2
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.19
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.16
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.12
Iron response of HepG2 cells 0.09
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.08
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.08
RNA-Seq and expression data from human adipose tissue 0.08
HEK293 TFAM Knockout Expression Study 0.06
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.03
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.02
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.01
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation